Sudarshan Hebbar

1.0k total citations
17 papers, 490 citations indexed

About

Sudarshan Hebbar is a scholar working on Surgery, Emergency Medicine and Infectious Diseases. According to data from OpenAlex, Sudarshan Hebbar has authored 17 papers receiving a total of 490 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Surgery, 3 papers in Emergency Medicine and 2 papers in Infectious Diseases. Recurrent topics in Sudarshan Hebbar's work include Pancreatitis Pathology and Treatment (4 papers), Endometrial and Cervical Cancer Treatments (2 papers) and COVID-19 Clinical Research Studies (2 papers). Sudarshan Hebbar is often cited by papers focused on Pancreatitis Pathology and Treatment (4 papers), Endometrial and Cervical Cancer Treatments (2 papers) and COVID-19 Clinical Research Studies (2 papers). Sudarshan Hebbar collaborates with scholars based in United States, South Korea and Malaysia. Sudarshan Hebbar's co-authors include Kenneth A. Stauderman, Charles Bruen, Keith W. Ward, Colin J. Meyer, Nosratola D. Vaziri, Glenn M. Chertow, Scott A. Reisman, Richard S. Muther, Beth A. Schodin and Walter L. Bender and has published in prestigious journals such as Stroke, Journal of the American Society of Nephrology and Critical Care Medicine.

In The Last Decade

Sudarshan Hebbar

14 papers receiving 485 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Sudarshan Hebbar 107 105 104 59 57 17 490
Shayan Moazeni 33 0.3× 74 0.7× 101 1.0× 6 0.1× 27 0.5× 6 684
Faiza Alam 121 1.1× 42 0.4× 90 0.9× 36 0.6× 76 1.3× 46 523
Stephanie Cham 85 0.8× 183 1.7× 35 0.3× 45 0.8× 85 1.5× 28 413
Yanping Gong 14 0.1× 185 1.8× 260 2.5× 11 0.2× 20 0.4× 49 668
Ahmed A. Hasan 14 0.1× 137 1.3× 219 2.1× 12 0.2× 116 2.0× 39 779
Kalyane Bach‐Ngohou 182 1.7× 205 2.0× 209 2.0× 3 0.1× 22 0.4× 49 946
Nancy Hua 16 0.1× 81 0.8× 190 1.8× 8 0.1× 32 0.6× 8 877
H. Lee 12 0.1× 33 0.3× 49 0.5× 21 0.4× 9 0.2× 34 347
M Congiu 188 1.8× 148 1.4× 197 1.9× 8 0.1× 329 5.8× 46 951
Shiyu Han 21 0.2× 37 0.4× 249 2.4× 11 0.2× 90 1.6× 45 608

Countries citing papers authored by Sudarshan Hebbar

Since Specialization
Citations

This map shows the geographic impact of Sudarshan Hebbar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sudarshan Hebbar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sudarshan Hebbar more than expected).

Fields of papers citing papers by Sudarshan Hebbar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sudarshan Hebbar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sudarshan Hebbar. The network helps show where Sudarshan Hebbar may publish in the future.

Co-authorship network of co-authors of Sudarshan Hebbar

This figure shows the co-authorship network connecting the top 25 collaborators of Sudarshan Hebbar. A scholar is included among the top collaborators of Sudarshan Hebbar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sudarshan Hebbar. Sudarshan Hebbar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Chawla, Lakhmir S., Patrick Murray, Stuart L. Goldstein, et al.. (2025). Inhibition of Calcium Release-Activated Calcium Channels to Treat Acute Kidney Injury: Design and Rationale of the KOURAGE Study a Randomized Trial. American Journal of Nephrology. 57(1). 42–52.
3.
Madácsy, Tamara, Árpád Varga, Tim Crul, et al.. (2023). Orai1 calcium channel inhibition prevents progression of chronic pancreatitis. JCI Insight. 8(13). 14 indexed citations
4.
Bruen, Charles, Edward A. Michelson, Maged Tanios, et al.. (2022). Auxora vs. placebo for the treatment of patients with severe COVID-19 pneumonia: a randomized-controlled clinical trial. Critical Care. 26(1). 101–101. 25 indexed citations
5.
Miller, Joseph, Yiyang Wu, Ashley Scott, et al.. (2021). Derivation and validation of the ED-SAS score for very early prediction of mortality and morbidity with acute pancreatitis: a retrospective observational study. BMC Emergency Medicine. 21(1). 16–16. 10 indexed citations
6.
Bruen, Charles, Joseph Miller, Caleb Mackey, et al.. (2021). Auxora for the Treatment of Patients With Acute Pancreatitis and Accompanying Systemic Inflammatory Response Syndrome. Pancreas. 50(4). 537–543. 44 indexed citations
7.
Bruen, Charles, Edward A. Michelson, Maged Tanios, et al.. (2021). Auxora Improves Outcomes in Patients With Severe COVID-19 Pneumonia: A Randomized Clinical Trial. SSRN Electronic Journal. 1 indexed citations
8.
Miller, Joseph M., Charles Bruen, Jeffrey Zhang, et al.. (2020). Auxora versus standard of care for the treatment of severe or critical COVID-19 pneumonia: results from a randomized controlled trial. Critical Care. 24(1). 502–502. 55 indexed citations
9.
Bruen, Charles, Joseph Miller, Jeffrey Zhang, et al.. (2020). 294: Auxora Improves D-Dimer Levels in Patients With Severe COVID-19 Pneumonia. Critical Care Medicine. 49(1). 134–134. 1 indexed citations
10.
Mizuma, Atsushi, Jong Youl Kim, Rachid Kacimi, et al.. (2018). Microglial Calcium Release-Activated Calcium Channel Inhibition Improves Outcome from Experimental Traumatic Brain Injury and Microglia-Induced Neuronal Death. Journal of Neurotrauma. 36(7). 996–1007. 29 indexed citations
11.
12.
Wilailak, Sarikapan, Chi‐An Chen, Joo-Hyun Nam, et al.. (2015). Distinguishing benign from malignant pelvic mass utilizing an algorithm with HE4, menopausal status, and ultrasound findings. Journal of Gynecologic Oncology. 26(1). 46–46. 37 indexed citations
13.
Warnock, David G., Sudarshan Hebbar, Joanne M. Bargman, et al.. (2012). Prospective Safety Study of Bardoxolone Methyl in Patients with Type 2 Diabetes Mellitus, End-Stage Renal Disease and Peritoneal Dialysis. Contributions to nephrology. 178. 157–163. 4 indexed citations
14.
Reisman, Scott A., Glenn M. Chertow, Sudarshan Hebbar, et al.. (2012). Bardoxolone Methyl Decreases Megalin and Activates Nrf2 in the Kidney. Journal of the American Society of Nephrology. 23(10). 1663–1673. 82 indexed citations
15.
Chan, Karen K. L., Chi‐An Chen, Joo‐Hyun Nam, et al.. (2012). The use of HE4 in the prediction of ovarian cancer in Asian women with a pelvic mass. Gynecologic Oncology. 128(2). 239–244. 76 indexed citations
16.
17.
Manley, Harold J., et al.. (2003). Factors associated with medication-related problems in ambulatory hemodialysis patients. American Journal of Kidney Diseases. 41(2). 386–393. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shayan Moazeni Breakdown of academic impact, for papers by Faiza Alam Breakdown of academic impact, for papers by Stephanie Cham Breakdown of academic impact, for papers by Yanping Gong Breakdown of academic impact, for papers by Ahmed A. Hasan Breakdown of academic impact, for papers by Kalyane Bach‐Ngohou Breakdown of academic impact, for papers by Nancy Hua Breakdown of academic impact, for papers by H. Lee Breakdown of academic impact, for papers by M Congiu Breakdown of academic impact, for papers by Shiyu Han
Rankless by CCL
2026